content

PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England

PCI Pharma Services is pleased to announce a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology, an important...

Abzena announces appointment of Petra Dieterich as Scientific Lead

Abzena, the leading Partner Research Organization (PRO) providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs) has announced the appointment...

In Preserved Ejection Fraction Trial Farxiga Shows Depth

DELIVER is the world's largest study of heart failure with intact ejection fraction. The DELIVER phase 3 trial produced favourable findings for AstraZeneca. It...

Illumina and Deerfield Management partner to accelerate drug development

SAN DIEGO Illumina, Inc., a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, announced a five-year...

Ashfield Engage acquires smart data organization PROPENSITY4

Ashfield Engage, part of UDG Healthcare has acquired PROPENSITY4 - a โ€˜smart dataโ€™ organization and leader in the healthcare insights and analytics arena. PROPENSITY4 integrates...

Citius Pharma selects global CRO, Biorasi to help expand phase 3 Mino-Lok trial to additional sites outside US

Citius Pharmaceuticals, Inc., a late-stage biopharmaceutical company, announced that it has selected Biorasi, LLC (Biorasi), a global clinical research organization (CRO), to help expand...

Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech Firms

Lonza and ALSA Ventures Colloboration: ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read